# Champions Oncology, Inc.: Form 10-Q for the period ended Jan 31, 2013

- Company: [Champions Oncology, Inc.](/companies/csbr.md) (CIK 771856)
- Form: 10-Q
- Filed: 2013-03-13
- Accepted by EDGAR: Mar 13, 2013, 16:20 ET
- Period: 2013-01-31
- Accession: 0001144204-13-014818
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/771856/000114420413014818/v336385_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/771856/000114420413014818/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2013-01-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 3 months, 2012-11-01 to 2013-01-31 | $592.0k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2012-05-01 to 2013-01-31 | $1.4m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2012-11-01 to 2013-01-31 | −$720.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2012-05-01 to 2013-01-31 | −$4.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2012-11-01 to 2013-01-31 | $5.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2012-05-01 to 2013-01-31 | $6.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2012-11-01 to 2013-01-31 | −$990.0k | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2012-05-01 to 2013-01-31 | −$4.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2012-11-01 to 2013-01-31 | −$0.02 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months, 2012-05-01 to 2013-01-31 | −$0.09 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months, 2012-05-01 to 2013-01-31 | −$3.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2012-05-01 to 2013-01-31 | $35.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2013-01-31 | $10.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2013-01-31 | $11.7m | us-gaap:AssetsCurrent |
| Total assets | at 2013-01-31 | $13.0m | us-gaap:Assets |
| Current liabilities | at 2013-01-31 | $2.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2013-01-31 | $3.7m | us-gaap:Liabilities |
| Shareholders' equity | at 2013-01-31 | −$7.6m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/771856/000114420413014818/v336385_10q.htm

Filed Mar 13, 2013.
Source: SEC EDGAR, the filing index for accession 0001144204-13-014818. Last ingested by Listed: Nov 10, 2026, 03:33 ET. No prices; not investment advice.
